| Market revenue in 2025 | USD 8.1 million |
| Market revenue in 2033 | USD 10.4 million |
| Growth rate | 3.3% (CAGR from 2026 to 2033) |
| Largest segment | Immunoassay |
| Fastest growing segment | Molecular Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Molecular Diagnostics, Immunoassay |
| Key market players worldwide | Abbott Laboratories, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Siemens Healthineers AG ADR, Danaher Corporation, Thermo Fisher Scientific Inc, BioMerieux SA, OraSure Technologies Inc, Chembio Diagnostic Systems Inc., SD Biosensor |
Publish Date: May 27, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| SD Biosensor | View profile | 251-500 | Suwon, Ch'ungch'ong-namdo, South Korea, Asia | www.sdbiosensor.com |
| OraSure Technologies Inc | View profile | 638 | 220 East First Street, Bethlehem, PA, United States, 18015 | www.orasure.com |
| Chembio Diagnostic Systems Inc. | View profile | 51-100 | Medford, New York, United States, North America | chembio.com/ |
| Danaher Corporation | View profile | - | - | - |
| Bio-Rad Laboratories, Inc. | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Syphilis Testing Market Outlook will help companies and investors design strategic landscapes.
Immunoassay was the largest segment with a revenue share of 72.84% in 2025.
Horizon Databook has segmented the Uae syphilis testing market based on molecular diagnostics, immunoassay covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE Syphilis Testing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into UAE Syphilis Testing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.